Takeda Pharmaceutical
TAK
#332
Rank
C$99.73 B
Marketcap
C$31.22
Share price
1.68%
Change (1 day)
57.23%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2026 (TTM): C$0.77 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are C$29.55 Billion. In 2025 the company made an earning of C$4.76 Billion, an increase over its 2024 earnings that were of C$3.20 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.77 B-83.8%
2025 C$4.76 B49.03%
2024 C$3.20 B-2.41%
2023 C$3.27 B-28.14%
2022 C$4.56 B-40.9%
2021 C$7.72 B78.24%
2020 C$4.33 B246.1%
2019 C$1.25 B-48.79%
2018 C$2.44 B-23.64%
2017 C$3.20 B21.7%
2016 C$2.62 B-253.01%
2015 -C$1.72 Billion-159.65%
2014 C$2.88 B13%
2013 C$2.54 B2.46%
2012 C$2.48 B-57.05%
2011 C$5.79 B-10.49%
2010 C$6.47 B-3.99%
2009 C$6.74 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$26.84 B 3,523.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$18.13 B 2,347.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$9.99 B 1,248.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$15.84 B 2,039.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$11.16 B 1,407.47%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$9.64 B 1,201.32%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$10.25 B 1,284.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-C$1.14 Billion-253.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
C$0.61 B-17.25%๐Ÿ‡ฎ๐Ÿ‡ณ India